Jeffrey Kadanoff is the Managing Director of Esplanade Ventures. Prior to Esplanade, he was the Chief Financial Officer for Knight Therapeutics Inc. (TSX: GUD), a leading Canadian specialty pharmaceutical company, from its inception as a publicly listed company in February 2014 until October 2017. Prior to joining Knight Therapeutics Inc. he was a Principal with Bain & Company where he served as a strategy consultant for 14 years. Additionally, he was Vice President-Strategic Planning and Development at Reitmans (Canada) Limited.
Jeffrey est détenteur d’un baccalauréat en génie chimique avec distinction et d’une mineure en gestion de l’Université McGill, ainsi que d’un MBA avec distinction de l’INSEAD.
+1 (514) 502-1135